Research Article

Prognostic Prediction Value of qSOFA, SOFA, and Admission Lactate in Septic Patients with Community-Acquired Pneumonia in Emergency Department

Table 2

Baseline characteristics of enrolled patients with CAP in ED.

All cohortsMVNMVUse of vasopressorsNonuse of vasopressors

N (%)33683 (24.7)253 (75.3)108 (32.1)228 (67.9)
Age (yrs)76 (61, 84)78 (67, 84)76 (61, 84)0.58478 (66, 87)75 (61, 83)0.065
Male, n (%)213 (63.4)54 (60.7)159 (64.4)0.53571 (65.7)142 (62.3)0.539
Comorbidities, n (%)
 COPD40 (11.9)14 (15.7)26 (10.5)0.19415 (13.9)25 (11.0)0.440
 CDVD48 (14.3)14 (15.7)34 (13.8)0.65018 (16.7)30 (13.2)0.391
 CBVD88 (26.2)20 (22.5)68 (27.5)0.35230 (27.8)58 (25.4)0.649
 Diabetes77 (22.9)15 (16.9)62 (25.1)0.11235 (32.4)42 (18.4)0.004
 CRD30 (8.9)9 (10.1)21 (8.5)0.64812 (11.1)18 (7.9)0.334
 HBD24 (7.1)6 (6.7)18 (7.3)0.8644 (3.7)20 (8.8)0.092
 Healthy28 (8.3)7 (7.9)21 (8.5)0.8525 (4.6)23 (10.1)0.091
Laboratory results
 WBC (×109/L)10.0 (6.7, 14.1)10.4 (6.7, 15.8)9.7 (6.8, 13.9)0.24410.8 (6.9, 16.0)9.8 (6.6, 13.9)0.180
 HGB (g/L)126 (115, 137)126 (115, 137)126 (116, 137)0.781126 (113, 136)127 (117, 138)0.314
 HCT (%)36.9 (31.8, 40.8)35.4 ± 9.237.2 (32.7, 40.7)0.35634.9 ± 9.137.3 (32.9, 40.9)0.092
 PLT (×109/L)184 (131, 251)155 (117, 241)192 (141, 251)0.109162 (123, 245)193 (141, 252)0.082
 ALB (g/L)36.2 (32.1, 39.1)34 ± 636.7 (32.8, 39.3)0.00234.2 ± 5.736.8 (33.0, 39.4)<0.001
 CREA (μmol/L)80.5 (60.8, 114.3)92.5 (71.2, 149.2)75.5 (59.9, 104)<0.00192 (69, 145.4)75.4 (60, 101.4)<0.001
 BUN (mmol/L)7.4 (5.3, 11.0)9.5 (6.5, 15.0)6.8 (5.0, 10.3)<0.0019.0 (6.0, 13.6)6.8 (5.1, 10.0)<0.001
 AST (U/L)30 (20, 56)36 (23, 81)29 (20, 53)0.09733 (23, 75)29 (20, 53)0.122
 ALT (U/L)20 (14, 37)17 (12, 45)21 (14, 36)0.69418 (12, 40)21 (14, 37)0.220
 TBIL (μmol/L)14.8 (9.6, 23.0)16.1 (10.6, 25)14 (9.5, 22.3)0.16416.0 (10.2, 25.9)13.9 (9.5, 21.9)0.089
 DBIL (μmol/L)6.4 (4.0, 10.6)7 (4.4, 12.3)6.1 (3.9, 9.7)0.0377.0 (4.4, 12.0)6.0 (3.8, 9.6)0.020
 K+ (mmol/L)3.8 (3.5, 4.2)4 (3.6, 4.5)3.8 (3.5, 4.1)0.0064.0 (3.5, 4.3)3.8 (3.5, 4.2)0.220
 PaO2/FiO2303 (262, 352)285 (244, 326)313 (272, 363)<0.001287 (246, 333)315 (274, 363)0.002
Vital signs
 SBP (mmHg)132 (119, 139)122 (100, 135)134 (125, 143)<0.001113 (97, 133)135 (126, 145)<0.001
 DBP (mmHg)68 (65, 76)65 (55, 71)70 (66, 78)<0.00162 (55, 69)72 (68, 78)<0.001
 HR (times/min)86 (78, 94)86 (79, 104)86 (78, 94)0.03389 (79, 106)86 (78, 92)<0.001
Severity scores
 CURB652 (2, 3)3 (3, 4)2 (1, 3)<0.0013 (2.5, 4)2 (1, 3)<0.001
 CRB652 (1, 3)3 (2, 3)2 (1, 2)<0.0013 (2, 3)2 (1, 2)<0.001
 PSI128 ± 40161 ± 37120 ± 36<0.001156 ± 38118 ± 36<0.001
 SOFA3 (2, 5)6 (5, 9)3 (2, 4)<0.0016 (4, 8)3 (2, 4)<0.001
 qSOFA2 (1, 2)3 (2, 3)1 (1, 2)<0.0012 (2, 3)1 (1, 2)<0.001
 Lactate (mmol/L)1.4 (1.1, 2.1)1.9 (1.3, 4.2)1.4 (1.1, 1.8)<0.0012.3 (1.4, 4.1)1.3 (1.0, 1.6)<0.001

Data are presented as n, n (%), or median (QL, QU). CAP: community-acquired pneumonia; MV: mechanical ventilation; NMV: nonmechanical ventilation; ED: emergency department; SCAP: severe community-acquired pneumonia; NSCAP: nonsevere community-acquired pneumonia; COPD: chronic obstructive pulmonary disease; CDVD: cardiovascular disease; CBVD: cerebrovascular disease; CRD: chronic renal disease; HBD: hepatobiliary disease; WBC: white blood cell; HGB: hemoglobin; HCT: hematocrit; PLT: platelet; ALB: albumin; CREA: creatinine; BUN: blood urea nitrogen; AST: aspartate aminotransferase; ALT: alanine aminotransferase; TBIL: total bilirubin; DBIL: direct bilirubin; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; CURB65: confusion, urea > 7 mmol/L, respiratory rate ≥ 30/min, blood pressure < 90 mmHg systolic and/or ≤60 mmHg diastolic, and age ≥ 65 years; CRB65: confusion, respiratory rate ≥ 30/min, blood pressure < 90 mmHg systolic and/or ≤60 mmHg diastolic, and age ≥ 65 years; PSI: pneumonia severity index; SOFA: sequential organ failure assessment; qSOFA: quick sequential organ failure assessment.